Sealantium Medical
Tissue Sealants and Hemostatic Agents
Company Overview
Snapshot
Founded in January 2011 by Orgad Laub, Sealantium Medical operates with 1–10 employees. The company has raised $11.57 million across two funding rounds. In June 2023, Sealantium Medical announced the completion of its Phase I/II clinical study.
Business overview
Sealantium Medical is a biosurgery company specializing in the development of proprietary next-generation tissue sealants and hemostatic agents for surgical applications. Its core product, sFilm-FS™, is a biodegradable and biocompatible polymeric film containing Fibrin Sealant, designed to enhance sealing capabilities and accelerate fluid coagulation and site adhesion. The company serves the medical industry, focusing on hospitals and critical care, and operates within the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology and Biomaterials & Tissue Engineering.
Strategic signal
In June 2023, Sealantium Medical completed its Phase I/II clinical study for sFilm-FS™, demonstrating promising early clinical results for safety and faster performance in controlling liver bleeding during surgery compared to market-leading products. This milestone signals significant progress in the company's product development pipeline and validates the potential of its novel mechanism of action, indicating a strong trajectory towards commercialization and market entry for its biosurgery solutions.
Company Intelligence Q&A
- What is Sealantium Medical's primary product?
- Sealantium Medical's flagship product is sFilm-FS™, a biodegradable and biocompatible polymeric film containing Fibrin Sealant, designed for tissue sealing and hemostatic applications during surgery.
- When was Sealantium Medical founded?
- Sealantium Medical was founded in January 2011.
- What was a significant recent milestone for Sealantium Medical?
- In June 2023, Sealantium Medical announced the completion of its Phase I/II clinical study for its sFilm-FS™ product, which demonstrated promising early clinical results.
- What is the total capital raised by Sealantium Medical?
- Sealantium Medical has raised a total of $11.57 million across two funding rounds.
- Which investor participated in Sealantium Medical's Series B capital raise?
- In October 2018, Sealantium Medical retained.